Clinical trial
Irinotecan and Cisplatin in Treating Patients With Locally Advanced or…
NCT00066391 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00066391 |
|---|---|
| Title | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer |
| Official title | Phase II Study of Irinotecan (CPT 11) and Cisplatin (CDDP) in Metastatic or Locally Advanced Penile Carcinoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Penile Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, irinotecan hydrochloride, neoadjuvant therapy |
| Start date | Jun 1, 2003 |
| Primary completion | Jan 1, 2006 |
| First posted | Aug 7, 2003 |
| Last update posted | Sep 24, 2012 |
| Countries | Belgium, France, Hungary, Netherlands, Poland, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: